2003Chongqing Yike Daxue xuebaoRequires access

Study on the bioequivalence of domestic loratadine in healthy volunteers

Yu Liu

Open publisher page 0 citations

Abstract

Objective:To study the bioequivalence and pharmacokinetics of two kinds of loratadine tablets in 20 healthy volunteers.Methods:An oral dose of 20mg of test or reference loratadine tablets was given according to a randomized 2-way cross-over design,blood samples were withdrawn up to 12 hours past administration,and plasma concentration of loratadine was determined by HPLC method.Results:The peak plasma levels (C max ) of loratadine test drug and reference drug were 8.59±6.70 or 9.59±8.22ng/ml respectively. The peak time (T max ) were 1.08±0.41 or 1.21±0.28h respectively,and AUC 0-t were 27.29±25.54 or 27.12±20.64ng·h/ml respectively.Conclusion:The result of statistic analysis and tow one-sided test suggest that the domestic loratadine talbet is bioequivalent to the imported tablet.The relative bioavailability of domestic loratadine tablets is 100.63%±14.27%.

About this research paper

What this paper is about

Objective:To study the bioequivalence and pharmacokinetics of two kinds of loratadine tablets in 20 healthy volunteers.Methods:An oral dose of 20mg of test or reference loratadine tablets was given according to a randomized 2-way cross-over design,blood samples were withdrawn up to 12 hours past administration,and plasma concentration of loratadine was determined by HPLC method.Results:The peak plasma levels (C max ) of loratadine test drug and reference drug were 8.59±6.70 or 9.59±8.22ng/ml respectively. The peak time (T max ) were 1.08±0.41 or 1.21±0.28h respectively,and AUC 0-t were 27.29±25.54 or 27.12±20.64ng·h/ml respectively.Conclusion:The result of statistic analysis and tow one-sided test suggest that the domestic loratadine talbet is bioequivalent to the imported tablet.The relative bioavailability of domestic loratadine tablets is 100.63%±14.27%.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To study the bioequivalence and pharmacokinetics of two kinds of loratadine tablets in 20 healthy volunteers.Methods:An oral dose of 20mg of test or reference loratadine tablets was given according to a randomized 2-way cross-over design,blood samples were withdrawn up to 12 hours past administration,and plasma concentration of loratadine was determined by HPLC method.Results:The peak plasma levels (C max ) of loratadine test drug and reference drug were 8.59±6.70 or 9.59±8.22ng/ml respectively. The peak time (T max ) were 1.08±0.41 or 1.21±0.28h respectively,and AUC 0-t were 27.29±25.54 or 27.12±20.64ng·h/ml respectively.Conclusion:The result of statistic analysis and tow one-sided test suggest that the domestic loratadine talbet is bioequivalent to the imported tablet.The relative bioavailability of domestic loratadine tablets is 100.63%±14.27%.

Key concepts: Loratadine, Bioequivalence, Bioavailability, Pharmacokinetics, Medicine, Desloratadine, Pharmacology, Plasma concentration

Related papers

Back to paper searchBrowse research topicsOriginal source
Study on the bioequivalence of domestic loratadine in healthy volunteers — Research Paper | ScholarLens